| P2093 | author name string | Goossens D | |
| P2860 | cites work | Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 |
| | Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 |
| | Reshaping human antibodies for therapy | Q28290936 |
| | Replacing the complementarity-determining regions in a human antibody with those from a mouse | Q28303497 |
| | Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension | Q29547330 |
| | Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface | Q29616401 |
| | By-passing immunization. Human antibodies from V-gene libraries displayed on phage | Q30831419 |
| | Antibody engineering: advances from the use of Escherichia coli expression systems | Q30987852 |
| | By-passing immunization: building high affinity human antibodies by chain shuffling | Q30988323 |
| | By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro | Q33191250 |
| | The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops | Q33191252 |
| | Analysis of the expression immunoglobulin gene repertoire by screening libraries derived from PCR-amplified cDNA | Q33268119 |
| | Immunization of hu-PBL–SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries | Q33274792 |
| | Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage λ vectors | Q33321464 |
| | Construction of representative immunoglobulin variable region cDNA libraries from human peripheral blood lymphocytes without in vitro stimulation | Q33370763 |
| | Making antibody fragments using phage display libraries | Q33392386 |
| | Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains | Q33392787 |
| | Cloning and sequencing of human lambda immunoglobulin genes by the polymerase chain reaction | Q33799015 |
| | Phage antibodies: filamentous phage displaying antibody variable domains | Q34031345 |
| | Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised inE. coli | Q35278468 |
| | C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids | Q59243363 |
| | REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H | Q61651778 |
| | Selective cloning of B cell hybridoma-specific rearranged immunoglobulin gene loci using the polymerase chain reaction | Q67300258 |
| | High level expression on a chimeric anti-ganglioside GD2 antibody: genomic kappa sequences improve expression in COS and CHO cells | Q67542904 |
| | Immunoglobulin complementarity-determining region grafting by recombinant polymerase chain reaction to generate humanised monoclonal antibodies | Q67990916 |
| | Expression of an antibody Fv fragment in myeloma cells | Q68002968 |
| | Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli | Q68030453 |
| | Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire | Q68066508 |
| | Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting Clq and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse | Q68066515 |
| | Catalytic antibodies | Q68512603 |
| | Specific amplification of rearranged immunoglobulin variable region genes from mouse hybridoma cells | Q68631230 |
| | Mouse-human chimeric monoclonal antibody to carcinoembryonic antigen (CEA): in vitro and in vivo activities | Q68726006 |
| | Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen | Q68791171 |
| | Expression in COS cells of a mouse-human chimaeric B72.3 antibody | Q68853107 |
| | Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions | Q69087348 |
| | Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli | Q69571764 |
| | Molecular recognition of antibody (IgG) by cellular Fc receptor (FcRI) | Q70068685 |
| | Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes | Q70141457 |
| | Single-chain antigen-binding proteins | Q70406917 |
| | Human monoclonal antibody against Forssman antigen | Q71342530 |
| | Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda | Q35331370 |
| | Antibody engineering: the use of Escherichia coli as an expression host | Q36001401 |
| | Engineered humanized dimeric forms of IgG are more effective antibodies | Q36231857 |
| | Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen | Q36355288 |
| | The immunogenicity of chimeric antibodies | Q36357164 |
| | The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain | Q36360927 |
| | The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region | Q36361038 |
| | Antibody-selectable filamentous fd phage vectors: affinity purification of target genes | Q36434701 |
| | Man-made antibodies | Q37624015 |
| | Localization of the binding site for the human high-affinity Fc receptor on IgG. | Q38347512 |
| | Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro | Q40068213 |
| | EB virus-induced B lymphocyte cell lines producing specific antibody | Q40101168 |
| | Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires | Q40407016 |
| | Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. | Q40819014 |
| | Assembly of a functional immunoglobulin Fv fragment in Escherichia coli | Q41278018 |
| | Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein | Q41621945 |
| | Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor | Q41626210 |
| | Rapid cloning of rearranged immunoglobulin heavy chain genes from human B-cell lines using anchored polymerase chain reaction | Q41639953 |
| | High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker | Q41642360 |
| | High level Escherichia coli expression and production of a bivalent humanized antibody fragment | Q41642366 |
| | Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11. | Q41646957 |
| | Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material | Q41650440 |
| | Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. | Q41697126 |
| | Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR. | Q41727057 |
| | Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli | Q41877495 |
| | Antibody production in silkworm cells and silkworm larvae infected with a dual recombinant Bombyx mori nuclear polyhedrosis virus | Q42071040 |
| | Structural repertoire of the human VH segments | Q42603998 |
| | Production of human hybridomas secreting antibodies to measles virus | Q42800318 |
| | Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. | Q42952442 |
| | Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function | Q43570976 |
| | Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host cell-target cell interaction | Q43891170 |
| | Fab assembly and enrichment in a monovalent phage display system | Q44820884 |
| | At the crossroads of chemistry and immunology: catalytic antibodies | Q45240248 |
| | Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo | Q45874080 |
| | A comparison of strategies to stabilize immunoglobulin Fv-fragments | Q46093365 |
| | Designing CD4 immunoadhesins for AIDS therapy | Q46215386 |
| | A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin | Q46249887 |
| | A CD 4: immunoglobulin fusion protein with antiviral effects against HIV. | Q46819379 |
| | Production of antibodies in transgenic plants | Q46882065 |
| | Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain | Q48306084 |
| | Reshaping human antibodies: grafting an antilysozyme activity | Q48327351 |
| | Antibody production in baculovirus-infected insect cells | Q52441844 |
| | Production of stable anti-digoxin Fv in Escherichia coli | Q54671984 |
| | Escherichia coli secretion of an active chimeric antibody fragment. | Q54748397 |
| | Production of antibody-tagged enzymes by myeloma cells: application to DNA polymerase I Klenow fragment. | Q54785467 |
| | The synthesis and in vivo assembly of functional antibodies in yeast. | Q54798974 |
| | Selection of phage antibodies by binding affinity | Q56690318 |
| | [34] Expression of functional antibody Fv and Fab fragments in Escherichia coli | Q57260270 |
| | Recombinant antibodies possessing novel effector functions | Q59068600 |
| | Production of functional chimaeric mouse/human antibody | Q59080874 |
| | The binding site for C1q on IgG | Q59084976 |
| P433 | issue | 6 | |
| P304 | page(s) | 517-544 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine | Q27709450 |
| P1476 | title | [Recombinant immunoglobulins] | |
| P478 | volume | 36 | |